BioSpace News Archive

Career Advice

How to Land a Biotech Job, According to Experts

We sat down with Associate Director of Talent Acquisition Jennifer Metivier and Chief People Officer Jennifer Peterson of Obsidian Therapeutics to discuss what type of candidates they prefer.

May 3, 2022
·
6 min read
·
Kaley Lefevre
Policy

Extradited Scientist Found Guilty of Stealing GSK Secrets

Gongda Xue has been found guilty in a Philadephia courtroom of stealing trade secrets from GlaxoSmithKline. This comes after his sister, Yu Xue, was also convicted for a similar crime.

May 3, 2022
·
3 min read
·
Alex Keown
Pfizer Leans Heavily on COVID-19 Vaccine, Treatments in Q1

Pfizer reported first-quarter revenues of $25.7 billion, a whopping 82% operational growth. This growth was largely driven by its COVID-19 vaccine developed with BioNTech and its antiviral drug, Paxlovid.

May 3, 2022
·
3 min read
·
Mark Terry
Policy

Embattled Researcher Sabatini Withdraws from Consideration for NYU Position

David Sabatini has withdrawn his name for consideration for a faculty post at New York University Langone Health.

May 3, 2022
·
2 min read
·
Alex Keown
Business

Life Sciences Industry has Eyes on Texas’ Innovation Corridor

Over the past several years, The Lone Star State has been growing in significance as a life sciences hub. Now the industry is flocking to Hays County and its Innovation Corridor.

May 3, 2022
·
4 min read
·
Alex Keown
Drug Development

Humacyte’s Engineered Blood Vessels in Final Push Toward BLA

Humacyte’s engineered blood vessels, human acellular vessels, are in a position to take tissue regeneration from a laboratory possibility to a commercial reality.

May 3, 2022
·
5 min read
·
Gail Dutton
Business

Genesis and Lilly Ink AI Collab Worth Up to $670M

Genesis Therapeutics and Eli Lilly have entered into a strategic collaboration to discover novel therapies utilizing Genesis’ AI platform.

May 3, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Horizon Rheumatoid Arthritis Trial Advances Following Successful Phase II Study

Horizon Therapeutics announced its Phase II dazodalibep (HZN-4920) clinical trial has met its primary endpoint. Dazodalibep is a treatment for patients with Rheumatoid Arthritis (RA).

May 3, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Business

At ISCT This Week, Cell & Gene Therapy Grows Up

BioSpace sat down with Sven Kili, 2022 ISCT Annual Meeting co-chair, to preview the event, which will focus on 4 key subject areas including launch and commercialization of cell and gene therapies.

May 3, 2022
·
5 min read
·
Heather McKenzie
Business

Teva Holds off Huntington’s Competitor, Resolves Opioid Cases

Teva announced that it had reached a deal with Lupin over Lupin’s Abbreviated New Drug Application (ANDA) for generic deutetrabenazine - an upcoming competitor to Hungtington’s drug Austedo.

May 3, 2022
·
3 min read
·
Mark Terry